期刊文献+

钠尿肽在急性呼吸衰竭性低氧血症病因诊断中的意义 被引量:1

An analysis to diagnostic utility of brain natriuretic peptide in subjects admitted to the ICU with hypoxic respiratory failure due to noncardiogenic and cardiogenic pulmonary edema
下载PDF
导出
摘要 ①目的分析B型钠尿肽(B-type natriuretic peptide BNP)对肺水肿呼吸衰竭性低氧血症病因诊断的临床意义。②方法回顾分析我院ICU71例患者BNP、心脏超声、胸部X线片、动脉血气分析及CVP等检测资料,根据患者临床特征进行诊断后分为心源性肺水肿呼吸衰竭性低氧血症组(CPE)、非心源性肺水肿呼吸衰竭性低氧血症组(ALI/ARDS),分析BNP的病因诊断中的意义。③结果 CPE组31例BNP均数为(1362±402)pg/mL;ALI/ARDS组40例BNP均数为(315±132)pg/mL;两组比较差异有统计学意义(P<0.001)。④结论 BNP在心源性及非心源性肺水肿性呼吸衰竭低氧血症的病因诊断有较好的价值。 Objective To analyze the role of B-type natriuretic peptide in subjects admitted to the ICU with hypoxic respiratory failure due to noncardiogenic and cardiogenic pulmonary edema.Methods Review 71 patients with acute hypoxic respiratory failure due to noncardiogenic and cardiogenic pulmonary edema were measured BNP、chest radiography、echocardiography and blood gas analysis.Two intensivists independently reviewed the records to determine the final diagnosis and divided into groups.Results The average concentrations of BNP of CPE group(31 patients)and ALI/ARDS group(40 patients) are respectively(1362±402)pg/mL and(315±132)pg/mL;There is notable statistical difference between the two groups(P0.001).Conclusion Rapid BNP assay can be used in patients with hypoxic respiratory failure due to noncardiogenic and cardiogenic pulmonary edema.
出处 《华北煤炭医学院学报》 2011年第2期149-150,共2页 Journal of North China Coal Medical College
关键词 钠尿肽 呼吸衰竭 心源性肺水肿 ALI/ARDS BNP.Respiratory failure.Cardiogenic pulmonary edema.ALI/ARDS
  • 相关文献

参考文献10

  • 1Bernard GR, Artigas A, Brigham KL, el al. The American -European Consensus Conference on ARDS: definitions,mechanisms, relevantoutcomes, and clinical trial coordination [ J ]. Am J Respir Crit Care Med. 1994.149:818.
  • 2Mennel LA, Maki DG. Infectious complications of Swan - Ganz pulmonary artery catheters : pathogenesis, epidemiology, prevention, and management [ J ]. Am J Respir Crit Care Med, 1994,149 : 1020.
  • 3Connora AF Jr, Speroff T, Dawson NV, et at. The effectiveness of right heart catheterization in the initial care of critically ill patients: SUPPORT Investigators [ J ]. JAMA, 1996,276:889.
  • 4de Lemos JA, McGuire DK, Drazner MH. B -type natriuretic peptide in cardiovascular disease[ J]. Lancet ,2003,362:316.
  • 5Sudoh T, Kangawa K, Minamino N, et al. A new natriuretie peptide . in porcine brain[ J]. Nature , 1988,332:78.
  • 6Kazanegra R, Cheng V, Garcia A, et al. A rapid test for B - type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure : a pilot study [ J ]. J Card Fail, 2001,7:21.
  • 7Maeda K, Tsutamoto T, Wada A, et al. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular enddiastolic pressure in patients with symptomatic left ventricular dysfunction [ J ]. Am Heart J, 1998,135:825.
  • 8Jefic D, Lee JW, Savoy - Moore RT, et al. Utility of B - type natriuretic peptide and N - terminal pro B - type natriuretic peptide in evaluation of respiratory failure in critically ill patients[ J]. Chest,2005, 128:288.
  • 9中华医学会.临床诊疗指南一重症医学分册[M].北京:人民卫生出版社,2009.107-128.
  • 10急性心力衰竭诊断和治疗指南[J].中华心血管病杂志,2010,38(3):195-208. 被引量:836

二级参考文献39

  • 1谢洪智,朱文玲.重组人脑利钠肽和硝酸甘油治疗急性失代偿性心力衰竭疗效和安全性的随机、开放、平行对照的多中心临床研究[J].中华心血管病杂志,2006,34(3):222-226. 被引量:228
  • 2中华医学会心血管病学分会 中华心血管病杂志编辑委员会.β肾上腺素能受体阻滞剂在心血管疾病应用的专家共识[J].中华心血管病杂志,2009,37:195-209.
  • 3中华医学会心血管病学分会 中华心血管病杂志编辑委员会.慢性心力衰竭诊断治疗建议.中华心血管病杂志,2007,35(12):1076-1095.
  • 4Nieminen MS, Bohm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26: 384-416.
  • 5Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 : the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC ( HFA ) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J, 2008, 29 : 2388-2442.
  • 6Hunt SA, American College of Cardiology, American Heart Association Task Force on Practice Guidelines ( Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure ). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart fa/lure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol, 2005, 46: e1-e82.
  • 7Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Aduks: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines : developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation, 2009, 119: 1977-2016.
  • 8Liang KV, Williams AW, Greene EL, et al. Acute decompensated heart failure and the cardiorenal syndrome. Crit Care Med, 2008, 36(1 Suppl) : S75-S88.
  • 9Chen D, Assad-Kottner C, Orrego C, et al. Cytokines and acute heart failure. Crit Care Med, 2008, 36(1 Suppl) : S9-S16.
  • 10Chen AA, Wood MJ, Krauser DG, et al. NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echocardiographic substudy. Eur Heart J, 2006, 27 : 839-845.

共引文献835

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部